Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous peripheral nerve block for pain and ischemic ulcers in arteriopathy
2009-017640-13Phase 4Active
- Sponsor
- Istituto Ortopedico Rizzoli
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levobupivacaine and oxycodone in arteriosclerosis obliterans, limb ischemia and arterial ulcer, sponsored by Istituto Ortopedico Rizzoli. Primary endpoint: Pain measurement by VAS. Started Sep 2010; status: active.
02
Drugs
levobupivacaineoxycodone
03
Conditions
arteriosclerosis obliteranslimb ischemiaarterial ulcer
Beyond the preview
Go deeper on 2009-017640-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017640-13.